Verrica Pharmaceuticals Inc

NASDAQ:VRCA   11:10:41 AM EDT
3.06
+0.14 (+4.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)125.75M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$4.25 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$3.11
50-Day MA$3.52
200-Day MA$5.74
See more pivots

Verrica Pharmaceuticals Inc Stock, NASDAQ:VRCA

44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380
UNITED STATES OF AMERICA
Phone: +1.434.453.3300
Number of Employees: 38

Description

Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.